The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric patients




How to Cite This Article: Jabbehdari S, Rahimian E, Jafari N, Sanii S, Khayatzadeh Kakhki S, Nejad Biglari H. The Clinical Features and Diagnosis of Metachromatic Leukodystrophy: A Case Series of Iranian Pediatric Patients. Iran J Child Neurol. Summer 2015;9(3):57-61.

Metachromatic leukodystrophy disorder (MLD) is one of the rare neurometabolic
diseases caused due to lack of saposin B and arylsulfatase A enzyme deficiency.

Materials & Methods
Eighteen patients diagnosed as metachromatic leukodystrophy in the Neurology
Department of Mofid Children’s Hospital in Tehran, Iran between 2010 and
2014 were included in our study. The disorder was confirmed by clinical,
EMG-NCV, arylsulfatase A enzyme checking and neuroimaging findings along
with neurometabolic and genetic assessment from reference laboratory in Iran.
We assessed age, gender, past medical history, developmental status, clinical
manifestations, and neuroimaging findings of 18 patients with metachromatic

From 18 patients, 80% were offspring from consanguineous marriages. A family
history of metachromatic leukodystrophy disease was positive for four patients.
Twelve patients had late infantile form of this disorder and six patients had juvenile form. A history of tonic type seizure was positive in 20% of the patients and tonic spasm was confirmed with clinical information. Electromyographgraphy (EMG) in 96% of patients was abnormal with demyelinating sensorimotor neuropathy pattern. MRI in all patients showed the leukodystrophic pattern as arcuate fibers sparing and subcortical rim in white matter and periventricular involvement. Our diagnosis was confirmed by EMG-NCV findings with sensorimotor neuropathy pattern and the assessment of arylsulfatase A enzyme function. 

MLD is an inheritance metabolic disorder, which was confirmed by the
assessment of arylsulfatase A enzyme function, peripheral blood leukocyte that
assessed in a referral laboratory in Iran.


Metachromatic leukodystrophy; Neurometabolic disorder; Children

Full Text:




Lugowska A, Mierzewska H, Bekiesińska-Figatowska M, Szczepanik E, Goszczańska-Ciuchta A, Bednarska-Makaruk M. A homozygote for the c.459+1G>A mutation in the ARSA gene presents with cerebellar ataxia as the only first clinical sign of metachromatic leukodystrophy. J Neurol Sci 2014; 338(1-2):214-7.

Kehrer C, Blumenstock G, Gieselmann V, Krageloh- Mann I. The natural course of gross motor deterioration in Metachromatic Leukodystrophy. Dev Med Child Neurol 2011;53:850–855.

i Dali C, Hanson LG, Barton NW, Fogh J, Nair N, Lund AM. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy. Neurology 2010; 75(21):1896-903.

Deconinck N, Messaaoui A, Ziereisen F, Kadhim H, Sznajer Y, Pelc K, et al .Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency. Eur J Paediatr Neurol 2008; 12(1):46-50. Epub 2007 Jul 5.

van der Voorn JP, Pouwels PJ, Kamphorst W, et al. Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. Am J Neuroradiol 2005; 26:442–446.

Tarasiuk J, Kapica-Topczewska K, Kułakowska A, Halicka D, Drozdowski W, Kornhuber J, et al. Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report. J Neural Transm 2012; 119(7):759-62.

Kehrer C, Blumenstock G, Raabe C, Krägeloh-Mann I. Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol 2011; 53(2):156-60.

Wittig EO, Marçallo FA, Pilotto RF, Mello LR. (Infantile metachromatic leukodystrophy in twins). Arq Neuropsiquiatr 1985; 43(3):331-4.

Groeschel S, í Dali C, Clas P, Böhringer J, Duno M, Krarup C, et al. Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy. Neurology 2012; 79(16):1662-70.

Yang J, Cao J, Li Y, Zheng H, Li J, Liang Y, et al. Analysis of phenotype and genotype in a family with late infantile metachromatic leukodystrophy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014; 31(5):615-8.

Sevin C, Cartier-Lacave N, Aubourg P. Gene therapy in metachromatic leukodystrophy. Int J Clin Pharmacol Ther 2009; 47 Suppl 1:S128-31.

Eichler F, Grodd W, Grant E, Sessa M, Biffi A, Bley A, et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. Am J Neuroradiol 2009; 30(10):1893-7.

Singh RK, Leshner RT, Kadom N, Vanderver AL. Isolated cranial nerve enhancement in metachromatic leukodystrophy. Pediatr Neurol 2009; 40(5):380-2.



  • There are currently no refbacks.

Copyright (c) 2015